BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10590151)

  • 1. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.
    Courageot MP; Frenkiel MP; Dos Santos CD; Deubel V; Desprès P
    J Virol; 2000 Jan; 74(1):564-72. PubMed ID: 10590151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
    Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
    Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effects of an iminosugar derivative on flavivirus infections.
    Wu SF; Lee CJ; Liao CL; Dwek RA; Zitzmann N; Lin YL
    J Virol; 2002 Apr; 76(8):3596-604. PubMed ID: 11907199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3.
    Tanaka Y; Kato J; Kohara M; Galinski MS
    Antiviral Res; 2006 Oct; 72(1):1-9. PubMed ID: 16730076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
    Miller JL; Tyrrell BE; Zitzmann N
    Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
    Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2006 Apr; 87(Pt 4):861-871. PubMed ID: 16528036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.
    Wang PG; Kudelko M; Lo J; Siu LY; Kwok KT; Sachse M; Nicholls JM; Bruzzone R; Altmeyer RM; Nal B
    PLoS One; 2009 Dec; 4(12):e8325. PubMed ID: 20016834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of N-linked oligosaccharides on the measles virus glycoproteins: importance for antigenicity and for production of infectious virus particles.
    Bolt G; Pedersen IR; Blixenkrone-Møller M
    Virus Res; 1999 May; 61(1):43-51. PubMed ID: 10426208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus.
    Mohan S; McAtamney S; Jayakanthan K; Eskandari R; von Itzstein M; Pinto BM
    Int J Antimicrob Agents; 2012 Sep; 40(3):273-6. PubMed ID: 22784856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.
    Warfield KL; Plummer EM; Sayce AC; Alonzi DS; Tang W; Tyrrell BE; Hill ML; Caputo AT; Killingbeck SS; Beatty PR; Harris E; Iwaki R; Kinami K; Ide D; Kiappes JL; Kato A; Buck MD; King K; Eddy W; Khaliq M; Sampath A; Treston AM; Dwek RA; Enterlein SG; Miller JL; Zitzmann N; Ramstedt U; Shresta S
    Antiviral Res; 2016 May; 129():93-98. PubMed ID: 26946111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.
    Qu X; Pan X; Weidner J; Yu W; Alonzi D; Xu X; Butters T; Block T; Guo JT; Chang J
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1036-44. PubMed ID: 21173177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.
    Norton PA; Menne S; Sinnathamby G; Betesh L; Cote PJ; Philip R; Mehta AS; Tennant BC; Block TM
    Hepatology; 2010 Oct; 52(4):1242-50. PubMed ID: 20658465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
    Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Endoplasmic Reticulum Alpha-Glycosidases as Potential Targets for Virus Control.
    Pérez-García LA; Martínez-Duncker I; Mora Montes HM
    Curr Protein Pept Sci; 2017; 18(11):1090-1097. PubMed ID: 27526926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.
    Whitby K; Pierson TC; Geiss B; Lane K; Engle M; Zhou Y; Doms RW; Diamond MS
    J Virol; 2005 Jul; 79(14):8698-706. PubMed ID: 15994763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
    Lu X; Mehta A; Dwek R; Butters T; Block T
    Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.